Larimar Therapeutics
Frank Nazzario is an accomplished professional with extensive experience in the pharmaceutical industry. Currently serving as Vice President of Commercial at Larimar Therapeutics Inc., Frank has previously held key leadership roles at BioCryst Pharmaceuticals, Inc., including Senior Vice President of US Sales, Vice President of US Sales, and Vice President of Marketing. Frank also contributed significantly to Spark Therapeutics, Inc. as U.S. Marketing Leader and Product Marketing Lead. Additional experience includes the position of Commercial Director at Trevena, Inc. and Director of Marketing at BTG.
This person is not in any teams
Larimar Therapeutics
Larimar Therapeutics, Inc. (Nasdaq: LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, CTI-1601, is currently being evaluated in the Phase 1 clinical program as a potential treatment for Friedreich’s ataxia, a rare and progressive genetic disease.